Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Short Interest Update
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) was the target of a large decline in short interest in January. As of January 31st, there was short interest totalling 17,060,000 shares, a decline of 5.4% from the January 15th total of 18,040,000 shares. Based on an average daily trading volume, of 2,640,000 shares, the short-interest […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) was the target of a large decline in short interest in January. As of January 31st, there was short interest totalling 17,060,000 shares, a decline of 5.4% from the January 15th total of 18,040,000 shares. Based on an average daily trading volume, of 2,640,000 shares, the short-interest […]
